Inflammatory lung injury after cardiopulmonary bypass is attenuated by adenosine A2A receptor activation

Journal of Thoracic and Cardiovascular Surgery

Volumn 136, Issue 5, 2008, Pages 1280-1288

  Lisle, Turner C ^a   Gazoni, Leo M ^a   Fernandez, Lucas G ^a   Sharma, Ashish K ^a   Bellizzi, Andrew M ^b   Schifflett, Grant D ^a   Laubach, Victor E ^a   Kron, Irving L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2A RECEPTOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTICLE; BLOOD SAMPLING; BODY TEMPERATURE; CANNULATION; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DISEASE SEVERITY; DRY WEIGHT; EXTRACORPOREAL CIRCULATION; HEPARINIZATION; LUNG EDEMA; LUNG INJURY; LUNG LAVAGE; MALE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD GAS ANALYSIS; BRONCHOALVEOLAR LAVAGE FLUID; CARDIOPULMONARY BYPASS; INTERFERON-GAMMA; INTERLEUKIN-1; INTERLEUKIN-6; LUNG; LUNG DISEASES; MALE; PEROXIDASE; PIPERIDINES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 56249095789     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.07.010     Document Type: Article

References (25)

1. Gibbon J.H. The application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 37 (1954) 171
2. Wan S., LeClerc J.L., and Vincent J.L. Inflammatory response to cardiopulmonary bypass. Chest 112 (1997) 676-692
3. Ng C.S.H., Wan S., Yim A.P., and Arifi A.A. Pulmonary dysfunction after cardiac surgery. Chest 121 (2002) 1269-1277
4. Edmunds L.H., and Colman R.W. Thrombin during cardiopulmonary bypass. Ann Thorac Surg 82 (2006) 2315-2322
5. Massoudy P., Zahler S., Becker B.F., Braun S.L., Barankay A., and Meisner H. Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass. Chest 119 (2001) 31-36
6. Gazoni L.M., Laubach V.E., Mulloy D.P., Bellizzi A., Unger E.B., Linden J., et al. Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion. J Thorac Cardiovasc Surg 135 (2008) 156-165
7. Reece T.B., Davis J.D., Okonkwo D.O., Maxey T.S., Ellman P.I., Li X., et al. Adenosine A2A analogue reduces long-term neurologic injury after blunt spinal trauma. J Surg Res 121 (2004) 130-134
8. Vinten-Johansen J., Zhao Z.Q., Corvera J.S., Morris C.D., Budde J.M., Thourani V.H., et al. Adenosine in myocardial protection in on-pump and off-pump cardiac surgery. Ann Thorac Surg 75 (2003) S691-S699
9. Reece T.B., Ellma P.I., Maxey T.S., Crosby I.K., Warrne P.S., Chong T.W., et al. Adenosine A2A receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantation. J Thorac Cardiovasc Surg 129 (2005) 1137-1143
10. Link A.A., Kino T., Worth J.A., McGuire J.L., Crane M.L., Chrousos G.P., et al. Ligand-activation of the adenosine A2A receptors inhibits IL-12 production by human monocytes. J Immunol 164 (2000) 436-442
11. Yang Z., Day Y.J., Toufektsian M.C., Xu Y., Ramos S.I., Marshall M.A., et al. Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. Circulation 114 (2006) 2056-2064
12. Grocott H.P., Mackensen G.B., Newman M.F., and Warner D.S. Neurologic injury during cardiopulmonary bypass in the rat. Perfusion 16 (2001) 75-81
13. Shao H., Shen Y., Liu H., Dong G., Qiang J., and Jing H. Simvastatin suppressed lung inflammatory response in a rat cardiopulmonary bypass model. Ann Thorac Surg 84 (2007) 2011-2019
14. Dong X., Liu Y., Du M., Wang Q., Tao Yu C., and Fan X. P38 mitogen-activated protein kinase attenuates pulmonary inflammatory response in a rat cardiopulmonary bypass model. Eur J Cardiothorac Surg 30 (2006) 77-84
15. Hayashi Y., Sawa Y., Fukuyama N., Nakazawa H., and Matsuda H. Inducible nitric oxide production is an adaptation to cardiopulmonary bypass-induced inflammatory response. Ann Thorac Surg 72 (2001) 149-155
16. Yoshitaka H., Yoshiki S., Motonobu N., Shinichiro T., Hajime I., Hisashi S., et al. P-selectin monoclonal antibody may attenuate the whole body inflammatory response induced by cardiopulmonary bypass. ASAIO J 46 (2000) 334-337
17. Schlensak C., Doenst T., Preuber S., Wunderlich M., Kleinschmidt M., and Bayersdorf F. Cardiopulmonary bypass reduction of bronchial blood flow: a potential mechanism for lung injury in a neonatal pig model. J Thorac Cardiovasc Surg 123 (2002) 1199-1205
18. Dodd-o J.M., Welsh L.E., Salazer J.D., Walinsky P.L., Peck E.A., Shake J.G., et al. Effect of bronchial artery blood flow on cardiopulmonary bypass-induced lung injury. Am J Physiol Heart Circ Physiol 286 (2004) H693-H700
19. Suzuki T., Fukuda T., Ito T., Inoue Y., Cho Y., and Kashima I. Continuous pulmonary artery perfusion during cardiopulmonary bypass prevents lung injury in infants. Ann Thorac Surg 69 (2000) 602-606
20. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 41 (2001) 775-787
21. Glover D.K., Riou L.M., Ruiz M., Sullivan G.W., Linden J., Rieger J.M., et al. Reduction of infarct size and post ischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium. Am J Physiol Heart Circ Physiol 288 (2005) H1851-H1858
22. Okusa M.D., Linden J., Huang L., Rieger J.M., Macdonald T.L., and Huynh L.P. A2A adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am J Physiol Renal Physiol 279 (2000) F809-F818
23. Rivo J., Zeira E., Galun E., Einav S., Linden J., and Matot I. Attenuation of reperfusion lung injury and apoptosis by A2A adenosine receptor activation is associated with modulation of bcl-2 and bax expression and activation of extracellular signal-regulated kinases. Shock 27 (2007) 266-273
24. Sullivan G.W., Rieger J.M., Scheld W.M., MacDonald T.L., and Linden J. Cylic AMP-dependant inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A2A receptor agonists. Br J Pharmacol 132 (2001) 1017-1026
25. Hayashi Y., Sawa Y., Nishimura M., Tojo S.J., Fukuyama N., Nakazawa H., et al. P-selectin participates in cardiopulmonary induced inflammatory response in association with nitric oxide and peroxynitrite production. J Thorac Cardiovasc Surg 120 (2000) 558-565